The Endocrine Files: Navigating the 2025 Diabetes Guidelines Updates
-
Register
- User - $35
*Supported by an educational grant from Novo Nordisk
This presentation will provide information about the new 2025 diabetes guidelines updates published by the American Diabetes Association. Updates to diagnosis, monitoring, lifestyle, and long-term concerns will be outlined as well as highlights of new evidence. Emphasis will be placed on medication treatment for T2DM.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.50 Contact Hours; 1.50 are Pharmacology
This activity is designated for 1.50 AAPA Category 1 CME credits. Approval is valid from 1/1/2026 to 12/31/2026. PAs should only claim credit commensurate with the extent of their participation
Expiration Date: December 31, 2026
$35
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Apply basics of the pathophysiology of diabetes to choosing treatment options.
-Identify key updates to the treatment of diabetes as per the Standards of Care in Diabetes – 2025.
-Identify how the intersection of socioeconomic factors and the functionality of the healthcare team impact diabetes outcomes.
Terri Schmitt
Executive Director, FNP
NPACE
Dr. Terri Schmitt is a Family Nurse Practitioner, educator, and diabetes specialist with more than 25 years of clinical experience in advanced practice across family, pediatrics, endocrinology, and chronic disease management. As Executive Director of NPACE, she leads national continuing education initiatives and brings a strong focus on evidence based care, clinical quality, and practical, applicable learning for advanced practice clinicians. In her clinical role with Galileo Health, she provides primary and chronic disease care with emphasis on diabetes management, patient education, and improving access for diverse populations – creating their diabetes education program and serving as consultant to other providers on complex diabetes cases. Dr. Schmitt’s academic work includes teaching and leading in one of the country’s largest FNP programs and contributing to diabetes education through research, national presentations, and curriculum development. A Fellow of the American Association of Nurse Practitioners, and a member of multiple APP organizations- she is most recognized for her 3-legged Boston Terrier with spina bifida and her love of all things John Mayer.
CE/CME INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. Approval is valid from 1/1/2026 to 12/31/2026 .
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
DISCLOSURES
Faculty
Contributing faculty, Terri Schmitt, PhD, APRN, FNP-BC, FAANP has disclosed no financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
